Muscarinic and Nicotinic Acetylcholine Receptor Agonists and Allosteric Modulators for the Treatment of Schizophrenia
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Muscarinic and Nicotinic Acetylcholine Receptor Agonists and Allosteric Modulators for the Treatment of Schizophrenia
Authors
Keywords
-
Journal
NEUROPSYCHOPHARMACOLOGY
Volume 37, Issue 1, Pages 16-42
Publisher
Springer Nature
Online
2011-09-28
DOI
10.1038/npp.2011.199
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A new automated method to assess the rat recognition memory: Validation of the method
- (2011) Caroline Chambon et al. BEHAVIOURAL BRAIN RESEARCH
- Behavioral effects of PNU-282987, an alpha7 nicotinic receptor agonist, in mice
- (2010) Paloma Vicens et al. BEHAVIOURAL BRAIN RESEARCH
- The enhancement of contextual fear conditioning by ABT-418
- (2010) Justin W. Kenney et al. BEHAVIOURAL PHARMACOLOGY
- Immediate and Sustained Improvements in Working Memory After Selective Stimulation of α7 Nicotinic Acetylcholine Receptors
- (2010) Stacy A. Castner et al. BIOLOGICAL PSYCHIATRY
- Effects of an Alpha 7-Nicotinic Agonist on Default Network Activity in Schizophrenia
- (2010) Jason R. Tregellas et al. BIOLOGICAL PSYCHIATRY
- Heterobiaryl and heterobiaryl ether derived M5 positive allosteric modulators
- (2010) Thomas M. Bridges et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Continuous administration of a selective α7 nicotinic partial agonist, DMXBA, improves sensory inhibition without causing tachyphylaxis or receptor upregulation in DBA/2 mice
- (2010) Karen E. Stevens et al. BRAIN RESEARCH
- Distinct Neural Pathways Mediate α7 Nicotinic Acetylcholine Receptor–Dependent Activation of the Forebrain
- (2010) Morten S. Thomsen et al. CEREBRAL CORTEX
- Insights into the neurodevelopmental origin of schizophrenia from postmortem studies of prefrontal cortical circuitry
- (2010) Monica Beneyto et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE
- Structural Determinants of Allosteric Agonism and Modulation at the M4Muscarinic Acetylcholine Receptor
- (2010) Vindhya Nawaratne et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Subpopulation of Neuronal M4 Muscarinic Acetylcholine Receptors Plays a Critical Role in Modulating Dopamine-Dependent Behaviors
- (2010) J. Jeon et al. JOURNAL OF NEUROSCIENCE
- RG3487, a Novel Nicotinic 7 Receptor Partial Agonist, Improves Cognition and Sensorimotor Gating in Rodents
- (2010) T. L. Wallace et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- A randomized double-blind study comparing 25 and 50 mg TC-1734 (AZD3480) with placebo, in older subjects with age-associated memory impairment
- (2010) Geoffrey C Dunbar et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The M1 Muscarinic Receptor Allosteric Agonists AC-42 and 1-[1'-(2-Methylbenzyl)-1,4'-bipiperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one Bind to a Unique Site Distinct from the Acetylcholine Orthosteric Site
- (2010) M. A. Jacobson et al. MOLECULAR PHARMACOLOGY
- Orthosteric and Allosteric Modes of Interaction of Novel Selective Agonists of the M1 Muscarinic Acetylcholine Receptor
- (2010) V. A. Avlani et al. MOLECULAR PHARMACOLOGY
- Muscarinic receptors induce LTD of NMDAR EPSCs via a mechanism involving hippocalcin, AP2 and PSD-95
- (2010) Jihoon Jo et al. NATURE NEUROSCIENCE
- Facilitation of Long-Term Potentiation by Muscarinic M1 Receptors Is Mediated by Inhibition of SK Channels
- (2010) Katherine A. Buchanan et al. NEURON
- Investigation into the efficacy of the acetylcholinesterase inhibitor, donepezil, and novel procognitive agents to induce gamma oscillations in rat hippocampal slices
- (2010) J.P. Spencer et al. NEUROPHARMACOLOGY
- Modes and Models of Forebrain Cholinergic Neuromodulation of Cognition
- (2010) Michael E Hasselmo et al. NEUROPSYCHOPHARMACOLOGY
- Activation of nicotinic α7 acetylcholine receptor enhances long term potentation in wild type mice but not in APPswe/PS1ΔE9 mice
- (2010) Andreas Söderman et al. NEUROSCIENCE LETTERS
- The M3-muscarinic receptor regulates learning and memory in a receptor phosphorylation/arrestin-dependent manner
- (2010) B. Poulin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Discovery and Characterization of Novel Subtype-Selective Allosteric Agonists for the Investigation of M1 Receptor Function in the Central Nervous System
- (2009) Evan P Lebois et al. ACS Chemical Neuroscience
- TOXIC EFFECT OF SCOPOLAMINE EYE DROPS IN CHILDREN
- (2009) B. HAMBORG-PETERSEN et al. ACTA OPHTHALMOLOGICA
- Evaluation of α7 Nicotinic Acetylcholine Receptor Agonists and Positive Allosteric Modulators Using the Parallel Oocyte Electrophysiology Test Station
- (2009) John Malysz et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- Stimulation of dopamine release by nicotinic acetylcholine receptor ligands in rat brain slices correlates with the profile of high, but not low, sensitivity α4β2 subunit combination
- (2009) David J. Anderson et al. BIOCHEMICAL PHARMACOLOGY
- A reversible model of the cognitive impairment associated with schizophrenia in monkeys: Potential therapeutic effects of two nicotinic acetylcholine receptor agonists
- (2009) Jerry J. Buccafusco et al. BIOCHEMICAL PHARMACOLOGY
- Selective α7 nicotinic receptor activation by AZD0328 enhances cortical dopamine release and improves learning and attentional processes
- (2009) Simon Sydserff et al. BIOCHEMICAL PHARMACOLOGY
- nAChR agonist-induced cognition enhancement: Integration of cognitive and neuronal mechanisms
- (2009) Martin Sarter et al. BIOCHEMICAL PHARMACOLOGY
- TC-5619: An alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophrenia
- (2009) T.A. Hauser et al. BIOCHEMICAL PHARMACOLOGY
- Positive allosteric modulation of α7 neuronal nicotinic acetylcholine receptors: lack of cytotoxicity in PC12 cells and rat primary cortical neurons
- (2009) Min Hu et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pentameric concatenated (α4)2(β2)3 and (α4)3(β2)2 nicotinic acetylcholine receptors: subunit arrangement determines functional expression
- (2009) A-L Carbone et al. BRITISH JOURNAL OF PHARMACOLOGY
- Treating the Cognitive Deficits of Schizophrenia with Alpha4Beta2 Neuronal Nicotinic Receptor Agonists
- (2009) Richard Radek et al. CURRENT PHARMACEUTICAL DESIGN
- Pharmacological comparison of muscarinic ligands: Historical versus more recent muscarinic M1-preferring receptor agonists
- (2009) Julia N. Heinrich et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Discovery of 4-(5-(4-Chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744) as a Novel Positive Allosteric Modulator of the α7 Nicotinic Acetylcholine Receptor
- (2009) Ramin Faghih et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of the First Highly M5-Preferring Muscarinic Acetylcholine Receptor Ligand, an M5 Positive Allosteric Modulator Derived from a Series of 5-TrifluoromethoxyN-Benzyl Isatins
- (2009) Thomas M. Bridges et al. JOURNAL OF MEDICINAL CHEMISTRY
- Differential Regulation of α7 Nicotinic Receptor Gene (CHRNA7) Expression in Schizophrenic Smokers
- (2009) Sharon Mexal et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- The muscarinic M1 receptor activates Nrf2 through a signaling cascade that involves protein kinase C and inhibition of GSK-3beta: connecting neurotransmission with neuroprotection
- (2009) Sandra Espada et al. JOURNAL OF NEUROCHEMISTRY
- A Selective Allosteric Potentiator of the M1 Muscarinic Acetylcholine Receptor Increases Activity of Medial Prefrontal Cortical Neurons and Restores Impairments in Reversal Learning
- (2009) J. K. Shirey et al. JOURNAL OF NEUROSCIENCE
- Procognitive and Neuroprotective Activity of a Novel 7 Nicotinic Acetylcholine Receptor Agonist for Treatment of Neurodegenerative and Cognitive Disorders
- (2009) R. Roncarati et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- α7 Nicotinic acetylcholine receptor activation prevents behavioral and molecular changes induced by repeated phencyclidine treatment
- (2009) Morten S. Thomsen et al. NEUROPHARMACOLOGY
- AC-260584, an orally bioavailable M1 muscarinic receptor allosteric agonist, improves cognitive performance in an animal model
- (2009) Stefania Risso Bradley et al. NEUROPHARMACOLOGY
- Molecular Mechanisms of Action and In Vivo Validation of an M4 Muscarinic Acetylcholine Receptor Allosteric Modulator with Potential Antipsychotic Properties
- (2009) Katie Leach et al. NEUROPSYCHOPHARMACOLOGY
- Pro-Cognitive and Antipsychotic Efficacy of the α7 Nicotinic Partial Agonist SSR180711 in Pharmacological and Neurodevelopmental Latent Inhibition Models of Schizophrenia
- (2009) Segev Barak et al. NEUROPSYCHOPHARMACOLOGY
- Functional Magnetic Resonance Imaging of Effects of a Nicotinic Agonist in Schizophrenia
- (2009) Jason R Tregellas et al. NEUROPSYCHOPHARMACOLOGY
- Mammalian Nicotinic Acetylcholine Receptors: From Structure to Function
- (2009) Edson X. Albuquerque et al. PHYSIOLOGICAL REVIEWS
- Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation
- (2009) L. Ma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Varenicline and P50 auditory gating in medicated schizophrenic patients: A pilot study
- (2009) Merilyne C. Waldo et al. PSYCHIATRY RESEARCH
- The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
- (2009) O. D. Howes et al. SCHIZOPHRENIA BULLETIN
- Prepulse inhibition deficits in schizophrenia are modified by smoking status
- (2009) Andrea A. Woznica et al. SCHIZOPHRENIA RESEARCH
- Correlation of prepulse inhibition and Wisconsin Card Sorting Test in schizophrenia and controls: Effects of smoking status
- (2009) Rachel A. Rabin et al. SCHIZOPHRENIA RESEARCH
- Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder
- (2009) Robert C. Smith et al. SCHIZOPHRENIA RESEARCH
- Weight effects associated with antipsychotics: A comprehensive database analysis
- (2009) Bruce Parsons et al. SCHIZOPHRENIA RESEARCH
- Initial Phase 2 Trial of a Nicotinic Agonist in Schizophrenia
- (2008) Robert Freedman et al. AMERICAN JOURNAL OF PSYCHIATRY
- Selective Muscarinic Receptor Agonist Xanomeline as a Novel Treatment Approach for Schizophrenia
- (2008) Anantha Shekhar et al. AMERICAN JOURNAL OF PSYCHIATRY
- Antipsychotic-like behavioral effects and cognitive enhancement by a potent and selective muscarinic M₁ receptor agonist, AC-260584.
- (2008) Kimberly E. Vanover et al. BEHAVIORAL NEUROSCIENCE
- Stimulation of the α4β2 nicotinic receptor by 5-I A-85380 improves auditory gating in DBA/2 mice
- (2008) Kristin M. Wildeboer et al. BRAIN RESEARCH
- Characterization of a CNS penetrant, selective M1muscarinic receptor agonist, 77-LH-28-1
- (2008) C J Langmead et al. BRITISH JOURNAL OF PHARMACOLOGY
- Functional Selectivity in GPCR Modulator Screening
- (2008) Terry Kenakin COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
- α7 nicotinic acetylcholine receptor activation ameliorates scopolamine-induced behavioural changes in a modified continuous Y-maze task in mice
- (2008) John P. Redrobe et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- FDA Warns of Adverse Events Linked to Smoking Cessation Drug and Antiepileptics
- (2008) Bridget M. Kuehn JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Genetic association analysis of tagging SNPs in alpha4 and beta2 subunits of neuronal nicotinic acetylcholine receptor genes (CHRNA4 and CHRNB2) with schizophrenia in the Japanese population
- (2008) Taro Kishi et al. JOURNAL OF NEURAL TRANSMISSION
- Novel Selective Allosteric Activator of the M1 Muscarinic Acetylcholine Receptor Regulates Amyloid Processing and Produces Antipsychotic-Like Activity in Rats
- (2008) C. K. Jones et al. JOURNAL OF NEUROSCIENCE
- Desensitization of Nicotinic Acetylcholine Receptors as a Strategy for Drug Development
- (2008) J. J. Buccafusco et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- M5 Muscarinic Receptor Knockout Mice Show Reduced Morphine-Induced Locomotion but Increased Locomotion after Cholinergic Antagonism in the Ventral Tegmental Area
- (2008) S. Steidl et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Centrally Active Allosteric Potentiators of the M4 Muscarinic Acetylcholine Receptor Reverse Amphetamine-Induced Hyperlocomotor Activity in Rats
- (2008) A. E. Brady et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Discovery and Characterization of Novel Allosteric Potentiators of M1 Muscarinic Receptors Reveals Multiple Modes of Activity
- (2008) J. E. Marlo et al. MOLECULAR PHARMACOLOGY
- Decreased cortical muscarinic receptors define a subgroup of subjects with schizophrenia
- (2008) E Scarr et al. MOLECULAR PSYCHIATRY
- Large recurrent microdeletions associated with schizophrenia
- (2008) Hreinn Stefansson et al. NATURE
- Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders
- (2008) P. Jeffrey Conn et al. NATURE REVIEWS DRUG DISCOVERY
- Nicotine-induced plasticity during development: Modulation of the cholinergic system and long-term consequences for circuits involved in attention and sensory processing
- (2008) Christopher J. Heath et al. NEUROPHARMACOLOGY
- Allosteric modulation of the muscarinic M4 receptor as an approach to treating schizophrenia
- (2008) W. Y. Chan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effect of R3487/MEM3454, a novel nicotinic α7 receptor partial agonist and 5-HT3 antagonist on sustained attention in rats
- (2008) Amir H. Rezvani et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- What CATIE Found: Results From the Schizophrenia Trial
- (2008) M. S. Swartz et al. PSYCHIATRIC SERVICES
- Effects of transdermal nicotine on episodic memory in non-smokers with and without schizophrenia
- (2008) Lindsay E. Jubelt et al. PSYCHOPHARMACOLOGY
- Early onset of antipsychotic response in the treatment of acutely agitated patients with psychotic disorders
- (2008) O AGID et al. SCHIZOPHRENIA RESEARCH
- Phencyclidine-Induced Cognitive Deficits in Mice Are Improved by Subsequent Subchronic Administration of the Novel Selective α7 Nicotinic Receptor Agonist SSR180711
- (2007) Kenji Hashimoto et al. BIOLOGICAL PSYCHIATRY
- The partial α7 nicotine acetylcholine receptor agonist S 24795 enhances long-term potentiation at CA3-CA1 synapses in the adult mouse hippocampus
- (2007) Laura Lagostena et al. NEUROPHARMACOLOGY
- It is not “either/or”: Activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood
- (2007) M PICCIOTTO et al. PROGRESS IN NEUROBIOLOGY
- Early nicotine withdrawal and transdermal nicotine effects on neurocognitive performance in schizophrenia
- (2007) Christopher G. AhnAllen et al. SCHIZOPHRENIA RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More